In the News
Cost-effectiveness of HPV vaccination after age 26 low, varies by risk factors
A model found that human papillomavirus (HPV) vaccination of men and women ages 27 to 45 years cost $2,005,000 per quality-adjusted life-year gained. Vaccinating patients in this age range who had more partners or had recently left a relationship was more cost-effective.
Risk for CVD events elevated years before type 2 diabetes diagnosis
A Danish study found that patients with type 2 diabetes had a twofold higher prevalence of cardiovascular disease (CVD) events as long as three decades before their diagnosis versus matched comparators.
MKSAP Quiz: UTI prevention in a patient with catheter
A 77-year-old woman is hospitalized for decompensated heart failure. An indwelling urinary catheter is placed to monitor hourly urine output, and intravenous diuretics are administered. What is the most appropriate management to prevent urinary tract infection (UTI)?
Urate-lowering therapy associated with benefit in patients with gout and CKD
The five-year risk of severe or end-stage chronic kidney disease (CKD) was lower in patients with CKD and gout who achieved a target serum urate level of less than 6 mg/dL compared to those who did not, data from the United Kingdom show.
Antipsychotics associated with risk for acute respiratory failure in older patients with COPD
A case-crossover study of Medicare beneficiaries with chronic obstructive pulmonary disease (COPD) found that risk for acute respiratory failure was higher within 14 days of antipsychotic use and increased with increasing age.
Vote for your favorite entry
I.M. Matters Weekly from ACP's cartoon caption contest continues. Readers can vote for their favorite caption to determine the winner.